Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
l-methylfolate + methylcobalamin + docosahexaenoic acid
- Development stage
- Unknown
- Lead developer
- SAIMIRRA INNOPHARM
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
L-methylfolate + methylcobalamin + docosahexaenoic acid is a nutritional supplement combination developed by SAIMIRRA INNOPHARM, primarily indicated for pregnancy support and the management of nutritional deficiencies. It combines three essential nutrients: L-methylfolate (the biologically active form of folate/vitamin B9), methylcobalamin (a coenzyme form of vitamin B12), and docosahexaenoic acid (DHA, an omega-3 fatty acid). L-methylfolate bypasses the metabolic steps required by folic acid, making it immediately available for the homocysteine-to-methionine conversion. Methylcobalamin acts as a cofactor for methionine synthase, supporting neurological function and red blood cell formation. DHA is a structural component of the brain and retina, essential for fetal neurodevelopment. Together, these ingredients meet the increased nutritional demands of preconception, pregnancy, and lactation while supporting fetal brain and neural development.
- Other names
- levomefolate + methylcobalamin + docosahexaenoic acid5-MTHF + MeB12 + DHAfolate + B12 + omega-3
02
Targets
Neuronal and retinal membrane phospholipidsMTR (Methionine synthase)
Beyond the preview
Go deeper on l-methylfolate + methylcobalamin + docosahexaenoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on l-methylfolate + methylcobalamin + docosahexaenoic acid.